Note s4
121 subscribers
329 photos
69 files
77 links
Download Telegram
๐Ÿ”บ ุงูˆู„ ุนุงุฆู„ุฉ Short acting (1-12h)

ู…ุชูƒูˆู†ุฉ ู…ู† ุดุฎุตูŠู†
Cortisone --- Oral
Hydrocortisone
ูŠุญุฌูˆุง ุจุงู„ุฎู„ุทุงุช ุงู„ูŠ ุชุณุชุฎุฏู… ู„ู„ูˆุฌู‡ ู„ุฐู„ูƒ ู‡ูˆ Topical

๐Ÿ”บุงู„ุนุงุฆู„ุฉ ุงู„ุซุงู†ูŠุฉ intermediate 12-36h

ุนุงุฆู„ุฉ ู…ู† ูค ู†ูุฑุงุช ุญุงู„ุชู‡ู… ุงู„ู…ุงุฏูŠุฉ ูˆุณุท
Predisone ุงู„ุงุจู†
Prednisolone ุงู„ุงุจ
Methylprednisolon ุงู„ุงู…
Triamcinolone ุงู„ุฒูˆุฌุฉ ุงู„ุซุงู†ูŠุฉ (ุงู„ุถุฑุฉ)
ุงู„ุงุจู† ุจุนุฏู‡ ุตุบูŠุฑ ูŠูƒุฏุฑ ูŠุงุฎุฐ Oral ูู‚ุท
ุงู„ุงุจ ุฑุฌุงู„ ุฌุจูŠุฑ ู…ูŠูƒุฏุฑ ูŠุจู„ุน ูˆุตุญุชู‡ ุชุนุจุงู†ุฉ ูุนุงูŠุด ุน ุงู„ุงุจุฑ IM & IV
ุงู„ุงู… (ู…ุซู„) ุชู‚ู„ุฏ ู‡ูˆุงูŠ ุชู‚ู„ุฏ ุถุฑุชู‡ุง ูˆุงู… ุถุฑุชู‡ุง๐Ÿ˜ ูˆู‡ุณู‡ ุงูƒูˆู„ูƒู… ู…ู†ูˆ ุถุฑุชู‡ุง ุงู„ู…ู‡ู… ู†ู†ุทูŠู‡ุง Topical + IA

Triamcinolone
T.. topical
IA.. Intraarticular
IM.. intramuscular
In. Inhaler
ุงู„ุถุฑุฉ ุงู„ุซุงู†ูŠุฉ ุงุฌุชูŠ ู…ู† ุนุงุฆู„ุฉ ุงู…ูˆุฑู‡ู… ุงู„ู…ุงุฏูŠุฉ ุนุงู„ูŠุฉ ุชุฒูˆุฌุช ุจุนุงุฆู„ุฉ ุงู…ูˆุฑู‡ู… ูˆุณุท ูŠุนู†ูŠ ุงุฎุฐุช ุตูุฉ ู…ู† ุงู‡ู„ู‡ุง ุงู„ูŠ ู‡ูŠ
No Mineralocorticoids

๐Ÿ”บุงู„ุนุงุฆู„ุฉ ุงู„ุซุงู„ุซุฉ long acting 36-55 h

ุฐูˆู„ูŠ ุงู…ูˆุฑู‡ู… ุงู„ู…ุงุฏูŠุฉ ูƒู„ุด ุนุงู„ูŠุฉ ู„ุฏุฑุฌุฉ ู…ุงุนุฏู‡ู… ฺฏุฏูˆุฑุฉ(ู…ุนุฏู†) ูŠุนู†ูŠ ุชุงุซูŠุฑู‡ู… ูู‚ุท ุณุชูŠุฑูˆูŠุฏ ุงู…ุง Mineralocorticoids ู…ุงุนุฏู‡ู…

Betamethasoneุงู„ุงุจ -- B ..toPical
Dexamethasoneุญุจูˆุจ ุฏูƒุณู†..ุงู„ุงู…(oral)
ุฐูˆู„ูŠ ุงู„ุงุซู†ูŠู† ุงู†ุทูŠู†ุงู‡ู… ุณุงุจู‚ุง ู„ู„ุญุงู…ู„ ุงุจุฑุฉ ุงูƒุชู…ุงู„ ุงู„ุฑุฆุฉ ูู…ู†ู†ุณู‰ ุฐูˆู„ูŠ IV, IM

#adrenal
๐Ÿ”–ู…ุฑุงุฌุนุฉ ุณุฑูŠุนุฉ ู„ู„ูƒุฌุฑ 4

๐Ÿ’€Drugs affecting bone metabolism

๐Ÿค”ุดู†ูˆ ู‡ูˆ paget disease โ“

๐Ÿ‘‰Is a disorder of bone remodeling that results in disorganization bone formation and enlarged or misshapen bones

๐ŸงุฒูŠู† ูŠุนู†ูŠ ูŠุดุจู‡ ู‡ุดุงุดุฉ ุงู„ุนุธุงู… ุŸ

ู„ุง ู„ุง ๐Ÿค“
๐Ÿ‘‰Paget disease limited to one or a few bones

๐Ÿค”ุดู†ูˆ ูŠุนู†ูŠ Osteomalasia ุŸ

๐Ÿ‘‰Is softening of the bones that is most often attributed to vitamin D deficiency


๐Ÿค”ุดู†ูˆ ู‡ูŠ ุงู„ Osteoclast ุŸ

๐Ÿ‘‰Are cells that break down bone , a process known as bone resorption

๐Ÿค”ูˆุดู†ูˆ ู‡ูŠ ุงู„ Osteoblast ุŸ

๐Ÿค”Called bone building cells synthesis new bone

๐Ÿค”ุฒูŠู† ุดูˆูƒุช ูŠุตูŠุฑ ุงู„ bone loss ุŸ

๐Ÿค”When bone resorption exceeds bone formation during the remodeling process
๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”
Prevention of Osteoprosis


๐Ÿ’ฌุดูˆู† ู†ู‚ู„ู„ ุงู„ bone loss ุจุงู„ postmenopausal women โ€ผ๏ธ

๐Ÿ‘‰Adequate intake of Ca , Vit D
๐Ÿ‘‰Weight bearing exercise
๐Ÿ‘‰Smoking cessation
๐Ÿ‘‰Avoidance of alcohol intake
๐Ÿ‘‰Avoidance of glucocorticoids

๐Ÿ’กูˆู†ู†ุชุจู‡ ู‡ู†ุง ุงู† ุญุชู‰ ุงูŠ ุดุฎุต ุนู†ุฏู‡ ุฎุทุฑ ุงู„ุงุตุงุจุฉ ุจู‡ุดุงุดุฉ ุงู„ุนุธุงู… ู„ุงุฒู… ูŠุชุฌู†ุจ ุงู„ูƒูˆุฑุชุฒูˆู† โ€ผ๏ธ

ู„ุงู† ู…ุซู„ุง ุงุณุชุฎุฏุงู… ๐Ÿ‘‡
Prednisone 5 mg / d for 3 months or more
ู…ู…ูƒู† ูŠุฒูŠุฏ ู…ู† ุฎุทุฑ ุงู„ุงุตุงุจุฉ ุจู‡ุดุงุดุฉ ุงู„ุนุธุงู… ๐Ÿ’€

๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”๐Ÿค”
Treamtment of Osteoporosis


ุงู„ุนู„ุงุฌ ูŠูƒูˆู† ู„ุงูŠ ู…ุฑุถู‰ ุŸ
๐Ÿ‘‰Postmenopausal women
๐Ÿ‘‰Men > 50 years old
๐Ÿ‘‰Pt previous osteoporotic fracture
๐Ÿ‘‰Bone mineral density 2.5 standard deviation or more below
๐Ÿ‘‰Osteopenia with high probability of future fracture

#Dr_Cube_Pharmacy ๐Ÿฆท
#bone
๐Ÿ”– ูƒู„ ุงู„ุงุฏูˆูŠุฉ ุงู„ู…ุฐูƒูˆุฑุฉ ุจู„ูƒุฌุฑ 4

โžก๏ธDrugs affecting bone metabolism


โžก๏ธCalcium supplement

๐Ÿ’ŠCalcium carbonate โžก๏ธ 40% elemental calcium
ูˆูŠุคุฎุฐ ู…ุน ุงู„ูˆุฌุจุฉ

๐Ÿ’ŠCalcium citrate โžก๏ธ 21% elemental calcium
ูˆู…ู…ูƒู† ู†ุงุฎุฐู‡ ู‚ุจู„ ุงูˆ ุจุนุฏ ุงู„ุงูƒู„

๐Ÿ’ŠVitamin D2 ( ergocalciferol )
๐Ÿ’ŠVitamin D3 ( Cholecalciferol)


โžก๏ธBisphosphonate

๐Ÿ’ŠAlendronate
๐Ÿ’ŠRisedronate
๐Ÿ’ŠZoledronic acid
๐Ÿ’ŠEtidronate
๐Ÿ’ŠIbandronate
๐Ÿ’ŠPamidronate
๐Ÿ’ŠTiludronate


โžก๏ธMonoclonal antibody

๐Ÿ’ŠDenosumab


โžก๏ธParathyroid agents

๐Ÿ’ŠTeriparatide โžก๏ธ recombinant parathyroid hormone

๐Ÿ’ŠAbaloparatide โžก๏ธanalog of parathyroid hormone related peptide


โžก๏ธSelective estrogen receptor modulators

๐Ÿ’ŠRaloxifen


โžก๏ธCalcitonin



#bone
#๏ธโƒฃ ุฃู‡ู… ู…ุง ุจฺ†ุงุจุชุฑ 3๏ธโƒฃ ุชฺฏุฏุฑ ุชุนุชู…ุฏู‡ ูˆุชุนุชุจุฑู‡ ู…ุฑุงุฌุนุฉ ู„ู‚ุฑุงูŠุชูƒ
๐Ÿ”ก๐Ÿ” ๐Ÿ” ๐Ÿ” 1๏ธโƒฃ

Biologic DMARDs:
ุจูŠ ู†ูˆุนูŠู†
๐Ÿ˜€.Biologic TNF-ฮฑ
ู…ุฌู…ูˆุนุฉ ุจูƒู„ู…ุฉ ุณูŠุงุฌูŠ
Certolizumab,etanercept,adlimumab,Golimumab, Infliximab

๐Ÿ˜€.Non biolgic TNF-ฮฑ
ู…ุฌู…ูˆุนุฉ ุจูƒู„ู…ุฉ ART
Abatacept, Rituximab, Tocilizumab

๐ŸŸกุงู„ูุนุงู„ูŠุฉ ุชุณุชุบุฑู‚ ุฃุณุจูˆุนูŠู† ูŠู„ุง ุชุจุฏูŠ
๐ŸŸกุฃุณุชุฎุฏู…ู‡ู… ุจุญุฐุฑ ูˆูŠ ู…ุฑุถู‰ ูุดู„ ุงู„ู‚ู„ุจ
๐ŸŸกู…ู…ูƒู† ูŠุฒูŠุฏูˆู† ู…ุฎุงุทุฑ ุงู„ูƒุงู†ุณุฑ
๐ŸŸกูŠุณุชุฎุฏู…ูˆู‡ู… ุจุนุฏ ูุดู„ Traditional DMARDS
๐ŸŸ ู…ู…ูƒู† ูŠุณูˆูˆู† ุชู†ุดูŠุท ู„ู€ hepatitis B
ูˆูŠุฒูŠุฏู† ู…ุฎุงุทุฑ ุงู„ู€ infections ู…ุซู„ุง ูŠุณูˆู† TB
๐Ÿ›‘ู…ู…ู†ูˆุน ุฃู†ุทูŠ TNF-ฮฑ ูˆ non TNF-ฮฑ
๐Ÿ›‘ู…ู…ู†ูˆุน ุฃู†ุทูŠู‡ู… ูˆูŠ live vaccine
Adalimumab
ู…ุซู„ ู…ุง ุฐูƒุฑุช ุจุงู„ุจูˆุณุช ุงู„ู‚ุจู„ู‡ ู‡ูˆ
recombinant Monoclonal Antibody

๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ู‡ูˆ ู†ูุณู‡ ุฑุงุญ ูŠู†ุนุงุฏ ุจุฃุบู„ุจ ุงู„ุฃุฏูˆูŠุฉ ูŠุฑุชุจุท ุจู€ TNF-ฮฑ ูˆูŠู…ู†ุนู‡ ู…ู† ุงู„ุฅุฑุชุจุงุท ุจุฑุณุจุชุฑ ุงู„ุฎู„ูŠุฉ ุจุงู„ุชุงู„ูŠ ู…ุงูƒูˆ ุงุณุชุฌุงุจุฉ ู…ู†ุงุนูŠุฉ ุจุงู„ุชุงู„ูŠ ู‚ู„ ุงู„ุฅู„ุชู‡ุงุจ ูˆุบูŠุฑู‡

๐Ÿ”˜ูŠู†ูˆุฎุฐ SC ูƒู„ ุฃุณุจูˆุน ุฃูˆ ูƒู„ ุฃุณุจูˆุนูŠู†
๐Ÿ”˜ูˆุงู‡ู… A.E: ุœ Agranulocytosis
Certolizumab
๐Ÿ’กู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู…
ูŠุฏู…ุฌูˆู‡ ูˆูŠ polyethylene glycol ุจุนู…ู„ูŠุฉ peglation "ุนู„ู…ูˆุฏ ูŠุฒูŠุฏูˆู† bioavailability ูˆ half-life ู„ู„ูู‡ู…"

๐Ÿ”˜ ูŠู†ูˆุฎุฐ SC ูƒู„ ุฃุณุจูˆุนูŠู†
Etanercept
ู‡ูˆ
genetically engineered fusion protein
ู…ู‡ู… ุชุนุฑูู‡ ูŠุฌูŠุจู„ูƒ ู‡ุงู„ุดูŠ ูˆูŠูƒู„ูƒ ู…ู†ูˆ ุงู„ุฃุฏูˆูŠุฉ ุนู†ุฏู‡ ู‡ุงู„ู…ูŠุฒุฉ ุชุฎุชุงุฑู‡

๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ู†ูุณู‡
๐Ÿ”˜ ูŠู†ูˆุฎุฐ SC ูƒู„ ุฃุณุจูˆุน
Golimumab
๐Ÿ’ก ู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู…

๐Ÿ”˜ ูŠู†ูˆุฎุฐ SC ูƒู„ ุดู‡ุฑ ู…ุน Methotrexate
๐Ÿ”˜ู…ู…ูƒู† ูŠุฒูŠุฏ ุงู†ุฒูŠู…ุงุช ุงู„ูƒุจุฏ
Infliximab
ู‡ูˆ
Chimeric Monoclonal Antibody
ู…ู‡ู… ูŠุฌูŠุจ ู‡ุงู„ุดูŠ ูˆูŠุฑูŠุฏ ุงู„ุฅุณู… ูˆุดุฑุญุชู‡ ุจุงู„ุจูˆุณุช ุดู„ูˆู† ุตุงุฑ

๐Ÿ’กู†ูุณ ุงู„ู…ูŠูƒุงู†ุฒู…
โš ๏ธ ู…ุง ูŠู†ุทูŠ ูˆุญุฏู‡ ู„ุฃู† ูŠุตูŠุฑู„ู‡ anti-infliximab Antibody ู„ุฐู„ูƒ ูŠู†ุทูˆู† ูˆูŠุงู‡ Methotrexate
๐Ÿ”˜ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ูจ ุฃุณุงุจูŠุน "ุดู‡ุฑูŠู†"
Abatacept
๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ูŠุชู†ุงูุณ ู…ุน CD28 ุนู„ู‰ ุงู„ุฅุฑุชุจุงุท ุจุงู„ุฑุณุจุชุฑุงุช ุงู„ู…ูˆุฌูˆุฏุฉ ุนู„ู‰ ุณุทุญ Macrophage ูˆ B cells

ุจุงู„ุชุงู„ูŠ ุฑุงุญ ูŠู…ู†ุน T cell ูŠุตูŠุฑู„ู‡ุง ุงุฑุชุจุงุท ุจุงู„ุฑุณุจุชุฑ ูŠุนู†ูŠ ู…ุง ุฑุงุญ ุชุชุญูุฒ ูุฑุงุญ ูŠู‚ู„ู„ ู…ู† ุงู„ุฅู„ุชู‡ุงุจ

๐Ÿ”˜ ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ูค ุฃุณุงุจูŠุน
๐Ÿ”˜ุฃู‡ู… upper respiratory infection: A.E
Rituximab
ู‡ูˆ ุฃูŠุถู‹ุง ูŠูƒูˆู†
Chimeric murine/human Monoclonal Antibody
ู…ู‡ู…ู…ู…ู…ู…

๐Ÿ’กุงู„ู…ูŠูƒุงู†ุฒู… ูŠุฑุชุจุท ุจู€ CD20 ุงู„ู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ B cells
ุจุงู„ุชุงู„ูŠ ูŠู‚ู„ู„ ุฎุฑูˆุฌ B cell

๐Ÿ”˜ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ูกูฆ-ูขูค ุฃุณุจูˆุน
๐Ÿ”˜ู…ู…ูƒู† ูŠุณูˆูŠ ุญุณุงุณูŠุฉ ููŠู†ุทูˆู† ูƒูˆุฑุชูŠุฒูˆู†ุŒ ุจุฑุงุณูŠุชูˆู„ุŒู…ุถุงุฏ ู‡ุณุชุงู…ูŠู† ู‚ุจู„ ูƒู„ ุฌุฑุนุฉ
ูˆุฃู‡ู… A.E: ูŠุณูˆูŠ hypotension ูˆุฎุงุตุฉ ุนู†ุฏ ุฃูˆู„ ุฃุณุชุฎุฏุงู…
Tocilizumab & Sarilumab

๐Ÿ’ก ุงู„ู…ูŠูƒุงู†ุฒู… ูŠุฑุชุจุทูˆู† ุจุงู„ุฑุณุจุชุฑ ู…ุงู„ IL-6 ุจุงู„ุชุงู„ูŠ ูŠู…ู†ุนูˆู† ุฎุฑูˆุฌ IL-6 ุจุงู„ุชุงู„ูŠ ูŠู‚ู„ ุงู„ุฅู„ุชู‡ุงุจ

ู…ู‡ู… ุงุชุฐูƒุฑ ุฐูˆู„ ุงู„ุซู†ูŠู† ุฃุณู…ุงุฆู‡ู… ุจูŠู‡ุง il ูŠุนู†ูŠ ูŠุดุชุบู„ูˆู† ุนู„ู‰ IL
ูˆุงูˆู„ ุญุฑููŠู† ู…ู† ุฃุณู…ุงุฆู‡ู… ุชู†ุทูŠ ูƒู„ู…ุฉ ุณุช ูŠุนู†ูŠ 6
ููŠุดุชุบู„ูˆู† ุนู„ู‰ IL-6


๐Ÿ”˜ูŠู†ูˆุฎุฐู† ุซู†ูŠู†ู‡ู… SC ูƒู„ ุฃุณุจูˆุนูŠู†
ูˆู…ุฑุงุช Tocilizumab ูŠู†ูˆุฎุฐ IV ูƒู„ ูค ุฃุณุงุจูŠุน
๐Ÿ”˜ุฃู‡ู… A.E: ูŠุณูˆูˆู† hyperlipidemia , Hypertension
Tofacitinib
๐Ÿ’กู‡ูˆ Janus-Kinase Inhibitors
ูŠุณุชุฎุฏู… ู„ุนู„ุงุฌ moderate-severe RA
ู„ู„ู…ุฑูŠุถ ุงู„ู„ูŠ ู…ุง ุชุญุณู‘ู† ุฃูˆ ู…ุง ุฃุชุญู…ู„ MTX

๐Ÿ“Œุญุชู‰ ุฃุณุชุฎุฏู…ู‡ ู„ุงุฒู… HB ุฃูƒุซุฑ ู…ู† 9g/dl
ู„ุฃู† ู…ู…ูƒู† ูŠุณูˆูŠ anemia ู„ุฐู„ูƒ ู„ุงุฒู… ุฃุฑุงู‚ุจ ุงู„ู€HB

โœ”๏ธ ูŠููุถู„ ุฃุฎู„ูŠ ุขุฎุฑ ุฃุฎุชูŠุงุฑ ู„ุฃู† ู…ู…ูƒู† ูŠุณูˆูŠู„ูŠ malignancy ูˆุฎุงุตุฉ ุงุฐุง ุงู„ู…ุฑูŠุถ ู…ุง ุงุณุชูุงุฏ ุงูˆ ู…ุง ุงุชุญู…ู„ ุจู‚ูŠุฉ ุงู„ุฃุฏูˆูŠุฉ
๏ปฟ
โฌ‡๏ธTreatment of Gout โฌ‡๏ธ

๐ŸŸกู‡ุฏููŠ ู…ู† ุงู„ุนู„ุงุฌ ุฃู†ุฒู„ ุงู„ู€ uric acid ุงู‚ู„ ู…ู†
<6mg/dl
ูˆุงู„ุนู„ุงุฌ ุฃู…ุง ุฃูˆู‚ู ุชุตู†ูŠุน ุฃูˆ ุฃุฒูŠุฏ ุทุฑุญ U.A

ุจุนู„ุงุฌ ุงู„ู†ูˆุจุงุช Acut gout ู‡ู†ุฉ ุชู„ุงุซุฉ CNC
Corticosteroid, NSAIDS, Colchicine

ูˆุชุฌูŠ ุงู„ู†ูˆุจุฉ ู„ุนุฏุฉ ุฃุณุจุงุจ ู…ู†ู‡ุง
๐Ÿ”ข. ูŠุดุฑุจ ูƒุญูˆู„ ู‡ูˆุงูŠ
๐Ÿ”ข. ูŠุงูƒู„ ูƒู…ูŠุงุช ูƒุจูŠุฑุฉ ู…ู† purine
๐Ÿ”ข. ู…ุฑุถ ูƒู„ูˆูŠ

ูˆู…ู…ูƒู† ูŠู†ุทูˆู† ุนู„ุงุฌ ูˆู‚ุงุฆูŠ ุญุชู‰ ู…ูŠุตูŠุฑ ุนู†ุฏูŠ ู†ูˆุจุฉ ูˆุฎุงุตุฉ ุงุฐุง ูƒุงู† ุนู†ุฏูŠ ุฃูƒุซุฑ ู…ู† ู†ูˆุจุชูŠู† ุจุงู„ุณู†ุฉ ุงูˆ ู…ุฑุถ ูƒู„ูˆูŠ ุงูˆ ุญุตูˆู‰ ุจุงู„ูƒู„ู‰ ุงูˆ tophi

๐Ÿ””ู‡ุณุฉ ู†ุณูˆู„ู ุจุงู„ุนู„ุงุฌ ูˆุฎุงุตุฉ Chronic Gout
ู‡ู†ุฉ ฺฏุฑูˆุจูŠู† ุฃู…ุง ุฃุฒูŠุฏ ุงู„ุทุฑุญ ุฃูˆ ุงู‚ู„ู„ ุงู„ุฅู†ุชุงุฌ ู…ุงู„ uric acid
๐Ÿ˜€.xanthaine oxidase Inhibitor ( allopurinol, febuxostat)
First line urate lowering agent

๐Ÿ˜„.Uricosuric agent (Probencid)
ู‡ุงูŠ ุชุฒูŠุฏ ุงู„ุทุฑุญ ู…ุงู„ u.a ูˆุชููŠุฏ ููŠ ุญุงู„ุฉ ุงู„ู…ุฑูŠุถ ู…ุง ุงุณุชุฌุงุจ ู„ู„ู€ ุงู„ฺฏุฑูˆุจ ุงู„ุฃูˆู„ ุฃูˆ ู…ุง ุงุชุญู…ู„ู‡ู…

๐Ÿ”– ูˆุงูˆู„ ู…ุง ุฃุจุฏูŠ ุฃุณุชุฎุฏุงู… ูˆุงุญุฏ ู…ู† ุฐู† ู„ุงุฒู… ุงู†ุทูŠ ูˆูŠุงู‡ู… Anti-inflammatory ุญุชู‰ ุงู…ู†ุน Acut gout ูˆูŠุณุชู…ุฑ ุนู„ูŠู‡ ุงู‚ู„ ุดูŠ ูฆ ุฃุดู‡ุฑ
Colchicine
ู‡ูˆ ู„ุง ู…ุณูƒู† ูˆู„ุง uricosuric ู‡ูˆ ู…ุฌุฑุฏ ูŠุฎูู ุงู„ุฃู„ู… ุงู„ู„ูŠ ูŠุตูŠุฑ ูˆูŠ Acute gout

๐Ÿ’กูŠุฑุชุจุท ุจุงู„ู€ tubulin,microtubulin ูˆูŠุณูˆูŠ depolymerization
ูˆูŠุฎุฑุจุท ุดุบู„ ุงู„ุฎู„ูŠุฉ ููŠู…ู†ุน neutrophils ุชุฑูˆุญ ู„ู„ู…ูุตู„ ุงู„ู…ุตุงุจ ูˆุชุณูˆูŠู„ูŠ ุงู„ุชู‡ุงุจ
ูˆูƒุฐู„ูƒ ูŠู…ู†ุน ุฃู†ู‚ุณุงู… ุงู„ุฎู„ูŠุฉ ู„ุฃู† ูŠุฑุชุจุท ุจู€ mitotic spindle

โœ”๏ธ ูŠุฎูู ุงู„ุฃู„ู… ุฎู„ุงู„ ูกูขุณ ู…ู† ุงู„ุฅุตุงุจุฉ
โœ…ู…ุง ูŠุตูŠุฑ ู†ู†ุทูŠ ุจุนุฏ ูฃูฆุณ ู…ู† ุงู„ุฅุตุงุจุฉ
๐Ÿ“ŒูŠุตูŠุฑู„ู‡ metabolism ุนู† ุทุฑูŠู‚ CYP3A4
๐Ÿ”˜ุฃู‡ู… A.E : ุœmyopathy, aplastic anemia

โš ๏ธู…ู…ู†ูˆุน ุฃู†ุทูŠ ู„ู„ุญุงู…ู„
โšก๏ธุฃุนุฏู„ ุงู„ุฌุฑุนุฉ ุงุฐุง ุฃุฎุฐู‡ ูˆูŠ CYP3A4 Inhibitors ุฃูˆ p-glycoprotein
ุฃูˆ ู…ุฑุถู‰ ุงู„ูƒู„ู‰
ูŠุชุจุน.....#DMARDs
๐Ÿ” ๐Ÿ” ๐Ÿ” ๐Ÿ” 2๏ธโƒฃ

Allopurinol
๐Ÿ’กูŠุฑุชุจุท ุจู€ oxidase enzyme ููŠู…ู†ุน ุขุฎุฑ ุฎุทูˆุชูŠู† ู…ู† ุชูƒูˆู† Uric acid

๐Ÿ˜ูุนุงู„ ุจุนู„ุงุฌ gout , ูˆ hyperuricemia ุงู„ู„ูŠ ุชุฌูŠ ู†ุชูŠุฌุฉ malignancy ุงูˆ Renal disease

โœ”๏ธูŠุชุญูˆู„ ุงู„ู‰ metabolite ูŠุณู…ูˆู‡ alloxanthine (oxypurinol)
ูˆ ุงู„ู€ half-life ู…ุงู„ุชู‡ู… ู…ู† ูกูฅ-ูกูจ ุณุงุนุฉ
ูŠู†ูˆุฎุฐ ู…ุฑุฉ ุจุงู„ูŠูˆู…
โœ…ุฃุนุฏู„ ุงู„ุฌุฑุน ููŠ ุญุงู„ุฉ ูƒุงู† GFR ุฃู‚ู„ ู…ู† 30
๐Ÿ”˜ุฃู‡ู… A.E : ุœskin rash
Febuxostat
ู†ูุณ ุฃุฎูˆู‡ ูŠู†ูˆุฎุฐ ุงูˆุฑู„ ุจุณ ุงู„ุญุณุงุณูŠุฉ ุจุงู„ุฌู„ุฏ ุฃู‚ู„

โš ๏ธุฃุณุชุฎุฏู…ู‡ ุจุญุฐุฑ ูˆูŠ ู…ุฑุถู‰ ุงู„ู‚ู„ุจ
ู„ุฃู† ูŠุณูˆูŠ ู…ุดุงูƒู„ ุจุงู„ู‚ู„ุจ ุนูƒุณ ุฃุฎูˆู‡ ุงู„ููˆฺฏ allopurinol
Probencid
oral uricosuric acid
๐Ÿ’กูŠุฒูŠุฏ ุทุฑุญ uric acid ู…ู† ุฎู„ุงู„ ุชุซุจูŠุท
urate - anion exchange in proximal tubule

โš ๏ธู…ู…ู†ูˆุน ุฃุณุชุฎุฏู…ู‡ ุฅุฐุง creatinine clearance ุฃู‚ู„ ู…ู† 50ml/min
๐Ÿ”˜ุฃู‡ู… A.E : ุœdermatologic reaction
Pegloticase
ู‡ูˆ ู…ุตู†ุน ูˆู…ุดุงุจู‡ ู„ุฃู†ุฒูŠู… ุฅุณู…ู‡ urate oxidase ุงูˆ uricase
ู…ู† ุฅุณู…ู‡ ุชุนุฑู ุฅุณู… ุงู„ุฃู†ุฒูŠู…

ูŠุญูˆู„ ุงู„ูŠูˆุฑูƒ ุงู„ู‰ allntoin ู…ุงุฏุฉ ุชุฐูˆุจ ุจุงู„ู…ูŠ ูˆุชุทู„ุน ุจุงู„ูƒู„ู‰

โœ”๏ธูŠุณุชุฎุฏู… ููŠ ุญุงู„ ุนุฏู… ุงู„ุงุณุชุฌุงุจุฉ ู„ุฃุฏูˆูŠุฉ first line
๐Ÿ”˜ูŠู†ูˆุฎุฐ IV Infusion ูƒู„ ุฃุณุจูˆุนูŠู†
๐Ÿ”˜ู…ู…ูƒู† ูŠุณูˆูŠ ุญุณุงุณูŠุฉ ููŠู†ุทูˆู† ู…ุถุงุฏ ู‡ุณุชุงู…ูŠู† ูˆ ูƒูˆุฑุชูŠุฒูˆู† ู‚ุจู„ ู…ุง ูŠุณุชุฎุฏู…ูˆู‡
๏ปฟ
#DMARDs
๐Ÿ“ŒูŠู‚ูˆู„ูƒ ู…ู†ูˆ ุฃู‚ูˆู‰ corticosteroids ู…ู† ู†ุงุญูŠู‡ Anti inflammation effect?? ูˆูŠูƒูˆู†ู† long acting?

1.. Betamethasone
2..Dexamethasone


๐Ÿ“Œู…ู†ูˆ ุฃู‚ูˆู‰ corticosteroids ู…ู† ู†ุงุญูŠู‡ amineralocortiocids ูŠุนู†ูŠ salt and water retaining effect??

Fluudrocortison

ุฃูƒุซุฑ ุดูŠ ู…ู‡ู…ุงุช ู‡ุฐู†ูŠ

ุงู„ุจุงู‚ูŠ ุงุทู„ุนูˆุง ุนู„ูŠู‡ู… ู…ู†ูˆ ุดูˆุฑุช ูˆู…ู†ูˆ ุงู†ุชูŠุฑู…ูŠุฏูŠุช

ูˆุงู„ ูˆู‚ุช

Short 1_12 hours

Intermediate 12_36 hours

Long 36_55 hou

#Adrenal glands ๐Ÿ’ฅ๐Ÿ’ฅ
Adverse effects of Long term corticosteroid therapy :
1๏ธโƒฃ Osteoporosis
ุจู‡ู„ ุญุงู„ุฉ ู…ู…ูƒู† ุงู†ุทูŠ Bisphosphonates

2๏ธโƒฃ Cushing-like syndrome

3๏ธโƒฃ Cataracts

4๏ธโƒฃ Hyperglycemiaโžก๏ธDM

5๏ธโƒฃ Topical therapy can cause skin atrophy, ecchymosis, and purple striae.

6๏ธโƒฃ Decrease growth in children

7๏ธโƒฃ glaucoma

8๏ธโƒฃ centripetal distribution of body fat

9๏ธโƒฃ increase risk of infection

๐Ÿ”Ÿ emotional disturbances

1๏ธโƒฃ1๏ธโƒฃ hypokalemia

1๏ธโƒฃ2๏ธโƒฃ hypertension

1๏ธโƒฃ3๏ธโƒฃ peripheral edema.


#adrenal chapter
ุตุงุจุฑูŠู†ุง ุŒ ูˆูƒูˆุฑุชูŠูƒูˆ
Spironolactone:
ุตุงุจุฑูŠู†ุง ุชุทุฑุฏ ุงู„ุตูˆุฏูŠูˆู… ูˆุชุญุชูุธ ุจุงู„ุจูˆุชุงุณูŠูˆู…
ูˆุจุงู„ุชุงู„ูŠ ุญุชุณุจุจ hyperkalemia

Corticosteroid:
ุนู…ู†ุง ูƒูˆุฑุชูŠูƒูˆ ูŠุญุชูุธ ุจุงู„ุตูˆุฏูŠูˆู… (ู„ู‡ุฐุง ูŠุณุจุจ ุถุบุท ูˆุงุญุชุจุงุณ)
ูˆูŠุทุฑุฏ ุงู„ุจูˆุชุงุณูŠูˆู… ูˆุญูŠุณุจุจ
Hypokalemia
ู…ุฎุชุตุฑ :
ูƒูˆุฑุชูŠูƒูˆ = ูŠูƒุฑู‡ ุงู„ุจูˆุชุงุณูŠูˆู…=hypokalemia
ุจูŠู†ู…ุง ุตุงุจุฑูŠู†ุง ุตุงุจุฑู‡ ุนู„ู‰ ุงู„ุจูˆุชุงุณูŠูˆู… ูˆุชุญุชูุธ
ุจูŠ ูู€ ุชุณุจุจ hyperkalemia

#Adrenal chapter
โญ•๏ธุœ
ุฃุฏูˆูŠุฉ RA ูˆุดฺฏุฏ ู†ุณุชุฎุฏู…ู‡ู… ู…ู‡ู…ุงุงุงุงุงุช ุฌุฏู‹ุง

Adalimumab โžก๏ธ weekly
or every other week

Certolizumab โžก๏ธ every 2 w

Etanercept โžก๏ธ once weekly

Golimumab โžก๏ธ once a month

Infliximab โžก๏ธ every 8 w

Abatacept โžก๏ธ every 4 w

Rituximab โžก๏ธ every 16โ€“24 w

Tocilizumab โžก๏ธ every 2 w
also IV every 4 w

Sarilumab โžก๏ธ every 2 w

#DMARDs
โค1
โญ•๏ธุœ
ุฃุฏูˆูŠุฉ bisphosphonates ู„ุนู„ุงุฌ OP ูˆุฃู‡ู… ุงู„ู…ู„ุงุญุธุงุช ุนู„ูŠู‡ุง

"Alendronate"
if oral tab โฉ daily or weekly
if effervescent โฉ weekly

"Ibandronate"
if oral tab โฉ daily or monthly
if intravenous โฉ every 3 month

"Risedronate"
if oral tab โฉ daily,weekly, or monthly
if oral delayed-release tab โฉ weekly

"Zoledronic acid"
intravenous โฉ yearly

โšก๏ธ ูƒู„ู‡ู… ู„ุงุฒู… ุฃุฎุฐู‡ู… ูˆูŠ ู…ุงุก ุทุจูŠุนูŠ ู„ุง ุญู„ูŠุจ ูˆู„ุง ูƒู‡ูˆุฉ ูˆู„ุง ุนุตูŠุฑ ..
โบ๏ธู„ุงุฒู… ูŠูƒูˆู† ุงู„ู…ุงุก ุญูˆุงู„ูŠ ูฆ-ูจ ุงูˆู†ุต ูŠุนู†ูŠ ุจุญุฏูˆุฏ ูกูฆู -ูกูจู  ู…ู„
โบ๏ธูŠู†ูˆุฎุฐูˆู† ู‚ุจู„ ุงู„ุฃูƒู„ ูˆุงู„ุฃุฏูˆูŠุฉ ุจู†ุต ุณุงุนุฉ (ุนุฏุง Ibandronate ุจุณุงุนุฉ)
โบ๏ธูŠุญุชุงุฌ ุชูƒุนุฏ ุงูˆ ุชูˆูƒู ู…ุฏุฉ ู†ุต ุณุงุนุฉ ู„ูƒู„ ุงู„ุฃุฏูˆูŠุฉ(ุนุฏุง Ibandronate ูŠุญุชุงุฌ ุณุงุนุฉ)

โœจุฅุณุชุซู†ุงุก ุจุณูŠุท ูู‚ุท
Risedronate delayed release tab
๐Ÿ”ขูŠุญุชุงุฌ ุฃู‚ู„ ุดูŠ ูค ุงูˆู†ุต ู…ู† ุงู„ู…ุงุก ูŠุนู†ูŠ ูจู ู…ู„ ุชู‚ุฑูŠุจุง
๐Ÿ”ขูˆูŠู†ูˆุฎุฐ ุจุนุฏ ูˆุฌุจุฉ ุงู„ูุทูˆุฑ ู…ุจุงุดุฑุฉ
#DMARDs
ูˆุจูŠู†ู…ุง ุฃู†ุง ุฃุทู„ุจ ู…ุดูŠุฆุชูƒุŒ ู‚ู„ุจูŠ ูŠุชู…ู†ู‰ ุฃู† ุชุชูู‚ ู…ุดูŠุฆุชูƒ ู…ุน ู…ุดูŠุฆูŽุชูŠ ู‡ุฐู‡ ุงู„ู…ูŽุฑุฉ ูŠุง ุงู„ู„ู‡.๐Ÿ’ž
-
Please open Telegram to view this post
VIEW IN TELEGRAM
โค4
Raloxifene agonist โžก๏ธ bone
Raloxifene antagonist โžก๏ธbreast +endometrium


Tamoxifen agonist โžก๏ธ bone + endometrium.
Tamoxifen antagonist โžก๏ธ breast

#pharmacology

*#Estrogen chapter
ุงู„ side effects ุงู„ู…ู…ูŠุฒุฉ ู…ู† NSAID ุฅู„ู‰ Diabetes


Salicylism (mild toxicity of salicylate ) โ†’mental confusion , dizziness,
tinnitus, hyperventilation confusion ,



Severe toxicity of salicylate โ†’ Restlessness, delirium, hallucinations, convulsions, coma , respiratory and metabolic acidosis, respiratory failure




Methotrexate โ†’ acute pneumonia-like syndrome, Cytopenias , mucusal ulceration



Hydroxychloroquine โ†’ skin discolouration+ eruption



Leflunomide โ†’flu-like syndrome , weight loss , alopecia, hypokalemia



Sulfasalazine โ†’ leukopenia



Adalimumab โ†’ agranulocytosis


Abatacept โ†’ upper respiratory infection


Tocilizumab+ sarilumab โ†’ hyperlipidemia, neutropenia, hypertension



Colchicine โ†’ myopathy, neutropenia, aplastic anemia, {alopecia( also hydroxychloroquine)}



Biosphonates โ†’ osteonecrosis of jaw , atypical femur fracture ,



Denosumab โ†’ Hypocalcemia , also osteonecrosis of jaw , atypical femur fracture ,


Relaxofene โ†’ leg cramps, venous thromboembolism



Teriparatide , abaloparide โ†’ hypercalcaemia , orthostatic hypotension, osteosarcoma

https://t.me/Quizpharmcy

#Antiinflammation
#DMARDs
ุงู„ุงุฑู‚ุงู… ู…ู† ุจุฏุงูŠุฉ ุฅู„ู‰ ู…ูˆุถูˆุน ุงู„ุณูƒุฑูŠ

Aspirin low dose โ†’ 3.5 hours half life

Aspirin high dose โ†’ 15 hours half life

Celecoxib โ†’ 11 half life

Ingest of 10 gram of aspirin is fetal to children

Methotrexate โ†’ 3__6 weeks appear effect


Hydroxychloroquine โ†’ 6 weeks __6 months appear effect


Sulfasalazine โ†’ 1__3 months appear effect


Adalimumab โ†’ weekly given


Certolizumab โ†’ every 2 weeks


Etanercept โ†’ weakly given


Golimumab โ†’ monthly given


Infliximab โ†’ every 8 weeks giving


Abatacept โ†’ every 4 weeks giving


Rituximab โ†’ 16_24 weeks giving



Tocilizumab+ sarilumab โ†’ every 2 weeks (S.C) ,,, every 4 weaks ( I.V)


Avoid Probencid if creatinine clearance less than 50 ml/ min

Colchicine โ†’ 12 Hours alleviate pain of acute gout,,,,,, should given within 36 hours of onset of attack


Pegloticase โ†’ every two weeks


Alendronate tab ( daily or weekly) , effervescent ( weekly)


Ibandronate โ†’ tab ( daily or monthly) , I.V ( every 3 months)


Risedronate โ†’ oral ( daily, weekly, monthly) , oral delayed tablets ( weekly)


Zoledronic acid โ†’ intravenous ( yearly)



Oral Biosphonates โ†’ drug holiday ( after 5 years)

Zoledronic acid โ†’ drug holiday ( after 3 years)



Denosumab โ†’ every 6 months

Teriparatide , abaloparide โ†’ not recommended more than 2 year



Calcitonin โ†’ after 5 years of menopause


https://t.me/Quizpharmcy

#DMARDs
#Antiinflammation
#bone
#๏ธโƒฃุฃู‡ู… ู…ุง ุจฺ†ุงุจุชุฑ 4๏ธโƒฃ ุชฺฏุฏุฑ ุชุนุชู…ุฏู‡ ูˆุชุนุชุจุฑู‡ ู…ุฑุงุฌุนุฉ ู„ู‚ุฑุงูŠุชูƒ ๐Ÿ’€๐Ÿ’€๐Ÿ’€๐Ÿ’€

ุจุงู„ุจุฏุงูŠุฉ ุฐุงูƒุฑ ุชุนุฑูŠูุงุช ู…ู…ูƒู† ูŠุฌู† ูู„ุงุฒู… ุชุนุฑูู‡ู†
Osteoporosis
ูŠุชู…ูŠุฒ ุงู†ูˆ ูƒุชู„ุฉ ุงู„ุนุธู… ุชู‚ู„ ูˆูŠูƒูˆู† ุงู„ู‡ูŠูƒู„ ุงู„ุนุธู…ูŠ ู‡ุด ุจุงู„ุชุงู„ูŠ ูŠูƒูˆู† ุนุฑุถุฉ ู„ู„ูƒุณุฑ ูˆูƒุฐู„ูƒ ู…ุฑุงุญ ุฃฺฏุฏุฑ ุงุชุญุฑูƒ
ูˆูŠุตูŠุฑ ุนู†ุฏ ุงู„ู†ุณุงุก ุจุนุฏ ุณู† ุงู„ูŠุฃุณ
ูˆุงู„ุฃุดุฎุงุต ุงู„ูƒุจุงุฑ ุจุงู„ุนู…ุฑ ุจูƒู„ุง ุงู„ุฌู†ุณูŠู†
๏ปฟ
Paget disease
ูŠุชู…ูŠุฒ ุงู†ูˆ ุงู„ุนุธู… ุฑุงุญ ูŠูƒูˆู† ุบูŠุฑ ู…ู†ุธู… ูˆู…ุชูˆุณุน ูˆุดูƒู„ู‡ ู…ุฎุฑุจุท
ูˆูŠุฎุชู„ู ุนู† OP ุงู†ูˆ ูŠุตูŠุจ ุนุธุงู… ู‚ู„ูŠู„ุฉ
ูˆูŠูƒูˆู† ุงู„ู…ุฑูŠุถ ูŠุนุงู†ูŠ ู…ู† ุฃู„ู… ูˆุชุดูˆู‡ุงุช ูˆูƒุณูˆุฑ
๏ปฟ
Osteomalacia
ู‡ูˆ ุชู„ูŠู† ุงู„ุนุธู… ูŠุนู†ูŠ ุงู„ุนุธู… ูŠุตูŠุฑ ู„ูŠู†
ูˆุณุจุจู‡ ู†ู‚ุต ููŠุชุงู…ูŠู† D
ูˆู‡ูˆ ู‡ุฐุง ู†ูุณู‡ ุงู„ู„ูŠ ูŠุตูŠุฑ ุนู†ุฏ ุงู„ุฃุทูุงู„ ูˆูŠุณู…ูˆู‡ ุงู„ูƒุณุงุญ rickets
๏ปฟ
prevention of OP
ุญุชู‰ ุฃู‚ู„ู„ ุงุญุชู…ุงู„ูŠุฉ ุฎุณุงุฑุฉ ุงู„ุนุธู… ุนู†ุฏ ุงู„ู†ุณุงุก ุจุนุฏ ุณู† ุงู„ูŠุฃุณ
๐Ÿ›‘ู„ุงุฒู… ุชุงูƒู„ ุจุงู„ูˆุฌุจุฉ ุชุญุชูˆูŠ vit. D,Ca ุจุดูƒู„ ูƒุงููŠ
๐Ÿ›‘ุชุณูˆูŠ ุชู…ุงุฑูŠู†
๐Ÿ›‘ุชูˆู‚ู ุชุฏุฎูŠู†
๐Ÿ›‘ุชู‚ู„ู„ ุงุณุชู‡ู„ุงูƒ ูƒุญูˆู„
ุงู„ุนู†ุฏู‡ ู†ู‚ุต ูƒุงู„ุณูŠูˆู… ู…ู…ูƒู† ูŠู†ุทูˆู‡:

๐Ÿ˜€Calcium carbonate
ูˆู‡ูˆ ุงู„ุดุงุฆุน ูˆู…ูˆ ุบุงู„ูŠ ูˆูŠุญุชูˆูŠ ุนู„ู‰
40% ca element
ูˆู„ุงุฒู… ูŠู†ูˆุฎุฐ ูˆูŠ ุงู„ุฃูƒู„ ุนู„ู…ูˆุฏ ุงู„ุฃู…ุชุตุงุต

๐Ÿ˜„calcium citrate
21% ca element
ูˆุนุงุฏูŠ ู‚ุจู„ ุงูˆ ุจุนุฏ ุงู„ุฃูƒู„
โš ๏ธู…ู…ู†ูˆุน ูŠู†ูˆุฎุฐ ุงู„ูƒุงู„ุณูŠูˆู… ูˆูŠ
iron , thyroid replacement, fluoroquinolone , Tetracycline

ุงู„ุนู†ุฏู‡ ู†ู‚ุต vit.D ูŠู†ุทูˆู‡:
ergocalciferol (D2)
cholecalciferol (D3)

Treatment of OP
ุฃูˆู„ ุนุงุฆู„ุฉ ูˆู‡ู…ุฉ
๐Ÿ’€bisphosphonates

Risedronate,Alendronate,Zoledronic acid
ู…ุฌู…ูˆุนูŠู† ุจูƒู…ุฉ ุฃุฑุฒ
preferred agent for treatment of postmenopausal osteoporosis

ุฃู…ุง ุจู‚ูŠุฉ ุงู„ุนุงุฆู„ุฉ ู…ุซู„ :
etidronate, Ibandronate, pamidroante, tiludronate
ุชุณุชุฎุฏู… ููŠ ุนู„ุงุฌ :
OP, Paget disease, bone metastasis, hypercalcemia of malignancy

๐Ÿ’กุœM.O.A : ุชุฑุชุจุท ุจู€ hydroxyapitate crystals ุงู„ู…ูˆุฌูˆุฏ ุจุงู„ุนุธุงู… ูˆุชู‚ู„ู„ ู…ู† osteoclast ุจุงู„ุชุงู„ูŠ ุชู‚ู„ู„ ู…ู† bone loss ูˆ fructure

โš ๏ธู…ู…ู†ูˆุน ุฃู†ุทูŠ ู„ู…ุฑุถู‰ ุงู„ูƒู„ู‰ ู„ุฃู† ู‡ูˆ ูŠู†ุทุฑุญ ุนู† ุทุฑูŠู‚ ุงู„ูƒู„ู‰
โœ”๏ธ ุงู„ู…ุง ูŠฺฏุฏุฑ ูŠุงุฎุฐ ุงู„ู€ oral ุฃู†ุทูŠ IV ุณูˆุงุก
Zoledronic acid , Ibandronate are alternative
๐Ÿ”˜ุฃู‡ู… A.E : ูŠุณูˆูŠ ู‡ูˆุงูŠ ู…ุดุงูƒู„ ุจุงู„ู…ุนุฏุฉ ู…ุซู„
esophagitis, esophageal ulcer
ูˆุญุชู‰ ุฃุญู„ู‡ุง ุงูˆ ุงู‚ู„ู„ู‡ุง ุงู†ุตุญ ุงู„ู…ุฑูŠุถ ูŠุจู‚ู‰ ูˆุงูƒู ู…ู† ูŠุงุฎุฐ ู‡ุงูŠ ุงู„ุฃุฏูˆูŠุฉ

โค๏ธ ู†ู†ุตุญ ุงู„ู…ุฑูŠุถ ุจุฃุฎุฐ ุฑุงุญุฉ ู…ู† ุงู„ุฃุฏูˆูŠุฉ durg holiday ูˆุฎุงุตุฉ
ุจุนุฏ ูฅ ุณู†ูŠู† ู…ู† ุงุณุชุฎุฏุงู… ุงู„ู€ oral
ุงูˆ ูฃ ุณู†ูŠู† ู…ู† ุงุณุชุฎุฏุงู… Zoledronic
ู„ุฃู† ุงู„ุฃุณุชุฎุฏุงู… ุงู„ู…ุทูˆู„ ู…ู…ูƒู† ูŠุณูˆูŠู„ูŠ ุชู†ุฎุฑ ุจุงู„ููƒ ุงูˆ ูƒุณุฑ ุจุงู„ุญูˆุถ ูˆู‡ุฐู† ู†ุงุฏุฑุงุช ุจุณ ู…ู…ูƒู† ูŠุตูŠุฑู†
๐Ÿ’€Denosumab

๐Ÿ’กุœM.O.A : ูŠุฑุชุจุท ุจุฑุณุชุจุฑ ุฅุณู…ู‡ ุฑุงู†ูƒู„ RANKL
receptor activator of nuclear factor kappa-b ligand
ูˆูŠุซุจุท osteoclast ุชูƒูˆู†ู‘ู‹ุง ูˆูˆุธูŠูุฉู‹
โœ”๏ธู…ูุถู„ ู„ู„ู€
postmenopausal Osteoporosis in women at high risk of fracture
๐Ÿ”˜ูŠุนุทู‰ SC ูƒู„ ูฆ ุฃุดู‡ุฑ
โœ… ูŠุนุชุจุฑ first line ู…ุซู„ ู…ฺฏู„ู†ุง ุจุนู„ุงุฌ PM-OP with high risk of fracture
๐Ÿ”˜ุฃู‡ู… A.E : ุœhypocalcemia
๏ปฟ
๐Ÿ’€Parathyroid agents
ุฏูˆุงุฆูŠู†
Teriparatide like PTH
Abaloparatide like PTHrP

๐Ÿ’กุœM.O.A: ู‡ุงูŠ ุงู„ุฃุฏูˆูŠุฉ ุชุฎุชู„ู ุนู† ุงู„ุจู‚ูŠุฉ
ู‡ูˆ ุงู†ูˆ ุชุดุชุบู„ ุนู„ู‰ ุชูƒูˆู† ุงู„ุนุธุงู… bone formation ุจุงู„ุชุงู„ูŠ ุชุญูุฒ osteoblast ูˆุชุฒูŠุฏ bone strength
๐Ÿ”˜ุฃู‡ู… A.E : ุœhypercalcemia, orthoststic hypotension
ูˆูƒุฐู„ูƒ osteosarcoma in rats๐Ÿฆซ

โœ”๏ธู„ุง ูŠู†ุตุญ ุจุงู„ุฃุณุชุฎุฏุงู… ู„ุฃูƒุซุฑ ู…ู† ุณู†ุชูŠู†
๐Ÿ’€Selective estrogen receptor modulator

ุงู„ุฃุณุชุฑูˆุฌูŠู† ูŠู„ุนุจ ุฏูˆุฑ ู…ู‡ู… ุจู€ ุชุซุจูŠุท osteoclast ูˆุชู†ุดูŠุท osteoblast ูู‚ู„ุฉ ู‡ุฐุง ุงู„ู‡ุฑู…ูˆู† ุนู†ุฏ ุงู„ู†ุณุงุก ูˆุฎุงุตุฉ Postmenopausal ูŠุคุฏูŠ ุงู„ู‰ ุฒูŠุงุฏุฉ osteoclast ูˆู…ู…ูƒู† ูŠุคุฏูŠ ุงู„ู‰ bone loss ุงุฐุง ู…ุง ุชุนุงู„ุฌุช

โบ๏ธู…ู…ูƒู† ุฃู†ุทูŠ estrogen supplements ุจุณ ู…ุง ุจูŠ ููˆุงุฆุฏ ู„ุฃู† ูŠุดุชุบู„ ุนู„ู‰ ูƒู„ ุงู„ุฑุณุจุชุฑุงุช ุงู„ู…ูˆุฌูˆุฏุฉ ุจุงู„ุฌุณู… ููŠุญูุฒ ุฑุณุจุชุฑุงุช bone,breast,uterus
ูู…ู…ูƒู† ูŠุณูˆูŠู„ูŠ ูƒุงู†ุณุฑ ู„ุฐู„ูƒ ุบูŠุฑ ู…ูุถู„
โœ”๏ธRaloxifene
ู‡ูˆ SERM
๐Ÿ’กุœM.O.A : ูŠุดุชุบู„ agonist ุนู„ู‰ ุงู„ุนุธู…
ูˆ antagonist ุนู„ู‰ breast, uterus
ุจุงู„ุชุงู„ูŠ ู…ุง ูŠุณูˆูŠู„ูŠ ูƒุงู†ุณุฑ
โบ๏ธูŠุนุชุจุฑ ุจุฏูŠู„ ููŠ ุญุงู„ุฉ ูุดู„ ุจู‚ูŠุฉ ุงู„ุฃุฏูˆูŠุฉ ู…ุซู„ bis ุงูˆ deno
๐Ÿ”˜ุฃู‡ู… A.E :ุœ hot flash, leg cramp , venous thromboembolism
๏ปฟ
๐Ÿ’€ Calcitonin

โบ๏ธ ูŠุนุงู„ุฌ OP ู„ู„ู†ุณุงุก ุงู„ู„ูŠ ุตุงุฑู„ู‡ุง ุฃู‚ู„ ุดูŠ ูฅ ุณู†ูˆุงุช ู…ู† ูˆุตู„ุช Postmenopausal
โบ๏ธ ูŠู‚ู„ู„ bone resorption
โบ๏ธ ุฃู‚ู„ ูุนุงู„ูŠุฉ ู…ู† ุจู‚ูŠุฉ ุงู„ุฃุฏูˆูŠุฉ
โบ๏ธ ุบูŠุฑ ู…ูˆุตู‰ ุจู‡ ู„ูุชุฑุฉ ุทูˆูŠู„ุฉ
๐Ÿ”˜ ูŠูˆุฎุฐ intranasal ุจุฎุงุฎ ุจุงู„ุฃู†ู
๐Ÿ”˜ ุฃู‡ู… A.E : ุœrhinitis ูˆ nasal symptoms
ุงูƒูŠุฏ ู„ุฃู† ุขู†ู‡ ุฌุงูŠ ุฃุฎุฐู‡ ุนู† ุทุฑูŠู‚ ุงู„ุฃู†ู
๏ปฟ
#bone
ู‡ุฐุง ู‡ู…ูŠู† ุงู„ diflunisal ู‡ู… ุจูŠ ููƒุฑุฉ ุญู„ูˆุฉ
ู„ูˆ ุงุฌู‡ ุณุคุงู„ ูˆฺฏุงู„ ู…ู†ูˆ ู…ู† ุฐู†ูŠ ุงู„ู†ุณุงูŠุฏ
ุงู„ูŠ ู…ุงูŠุนุงู„ุฌ ุงู„ Fever
ู„ุงู† ุงู„ diflunisal ู‡ูˆ ุงู„ูˆุญูŠุฏ ู…ู† ุนุงุฆู„ู‡ ุงู„ salicylates ุงู„ูŠ ู…ุงูŠุนุจุฑ BBB
ูŠุนู†ูŠ ู…ุง ูŠูˆุตู„ ู„ู„CNS ุญุชู‰ ูŠุณูˆูŠ resetting of thermostats
ูุจุงู„ุชุงู„ูŠ ู…ุงูŠุนุงู„ุฌ ุงู„fever
ู†ู„ุญ ุดูˆูŠู‡ ุจุนุฏ ุจุงู„ุฌุฏูˆู„
ู„ูˆ ุทู„ุจ longest duration of action
1-sulindac
2-piroxicam
3-meloxicam
ูˆู…ู…ูƒู† ู…ุง ูŠุฌูŠุจู‡ุง ุจู‡ุงูŠ ุงู„ุตูŠุบุฉ
ู…ู…ูƒู† ูŠฺฏู„ูƒ ู…ู†ูˆ ุงู„ูŠ ูŠุญุชุงุฌ once daily dosing

ุงู„ุงุฑุฎุต ูˆุนู†ุฏู‡ ุณุฌู„ ุทูˆูŠู„ ู…ู† ุงู„safety
ุงูƒูŠุฏ ุงู„ุงุณุจุฑูŠู†


ุงู‚ู„ ูˆุงุญุฏ ุจูŠู‡ู… ุณุงูŠุฏ ุงููƒุช (ุงูƒุซุฑ ูˆุงุญุฏ ุขู…ุงู† ุนู„ู‰ ู…ุฑุถู‰ cvs) ู‡ูˆ naproxen
#Antiinflammation
๐Ÿ‘3
ู…ู„ุฎุต NSAIDS ูˆุงู„ุนุธุงู… ๐Ÿ‘‡๐Ÿป